Amalia Lamana
Madrid, MD 28006, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Differential Expression of Galectin-1 and Galectin-9 in Immune-Mediated Inflammatory Diseases.
Journal: International journal of molecular sciences
Published: August 11, 2025
Vasoactive intestinal peptide exerts an osteoinductive effect in human mesenchymal stem cells.
Journal: BioFactors (Oxford, England)
Published: January 16, 2024
Genetic variants regulating the immune response improve the prediction of COVID-19 severity provided by clinical variables.
Journal: Scientific reports
Published: December 14, 2023
Galectin-1: A Potential Biomarker Differentiating between Early Rheumatoid Arthritis and Spondyloarthritis.
Journal: Journal of clinical medicine
Published: September 06, 2022
VIP/VPAC Axis Expression in Immune-Mediated Inflammatory Disorders: Associated miRNA Signatures.
Journal: International journal of molecular sciences
Published: July 07, 2022
Genetic LGALS1 Variants Are Associated with Heterogeneity in Galectin-1 Serum Levels in Patients with Early Arthritis.
Journal: International journal of molecular sciences
Published: June 01, 2022
Human CD4+CD45RA+ T Cells Behavior after In Vitro Activation: Modulatory Role of Vasoactive Intestinal Peptide.
Journal: International journal of molecular sciences
Published: December 10, 2021
The Neuropeptide VIP Limits Human Osteoclastogenesis: Clinical Associations with Bone Metabolism Markers in Patients with Early Arthritis.
Journal: Biomedicines
Published: November 10, 2021
Comparative Study of Senescent Th Biomarkers in Healthy Donors and Early Arthritis Patients. Analysis of VPAC Receptors and Their Influence.
Journal: Cells
Published: October 27, 2020
Validation of galectin-1 as potential diagnostic biomarker of early rheumatoid arthritis.
Journal: Scientific reports
Published: June 15, 2020
Last Updated: 09/26/2026